Concord Biotech Limited (CONCORDBIO.NS)

INR 2147.65

(-1.18%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020
Revenue 9.98 Billion 8.53 Billion 7.08 Billion 6.04 Billion 5.12 Billion
Cost of Revenue 2.41 Billion 1.8 Billion 1.77 Billion 1.2 Billion 1.38 Billion
Gross Profit 7.56 Billion 6.72 Billion 5.3 Billion 4.83 Billion 3.74 Billion
Operating Expenses 1.45 Billion 3.83 Billion 2.94 Billion 1.8 Billion 1.59 Billion
Selling, General and Administrative Expenses 442.38 Million 342 Million 320.17 Million 204.57 Million 219.04 Million
Research and Development Expenses - 328.29 Million 290.87 Million - -
Other Expenses - 353.09 Million 9.73 Million 11.25 Million -
Cost and Expenses 3.9 Billion 5.63 Billion 4.72 Billion 3 Billion 2.98 Billion
Operating Income 6.26 Billion 3.26 Billion 2.43 Billion 3.06 Billion 1.93 Billion
Interest Expense 31.26 Million 45.1 Million 54.84 Million 6.66 Million 11.67 Million
Income Tax Expense 1.04 Billion 819.27 Million 625.89 Million 778.33 Million 445.26 Million
Earnings before Tax 4.12 Billion 3.22 Billion 2.37 Billion 3.12 Billion 2.13 Billion
Net Income 3.08 Billion 2.4 Billion 1.74 Billion 2.34 Billion 1.69 Billion
Earnings Per Share Basic 29.45 22.95 16.72 22.45 16.16
Earnings Per Share Diluted 29.45 22.95 16.72 22.45 16.16
Weighted Average Shares Outstanding 104.61 Million 104.61 Million 104.61 Million 104.61 Million 104.61 Million
Weighted Average Shares Outstanding (Diluted) 104.61 Million 104.61 Million 104.61 Million 104.61 Million 104.61 Million
Gross Margin 0.76 0.79 0.75 0.80 0.73
EBIT Margin 0.47 0.45 0.42 0.55 0.42
Profit Margin 0.31 0.28 0.25 0.39 0.33
EBITDA 4.65 Billion 3.83 Billion 2.97 Billion 3.41 Billion 2.14 Billion
Earnings Before Tax Margin 0.63 0.38 0.34 0.51 0.38

Income Statement Charts